NDT Advance Access originally published online on April 28, 2008
Nephrology Dialysis Transplantation 2008 23(10):3146-3151; doi:10.1093/ndt/gfn208
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis
1 Department of Paediatric Nephrology 2 Department of Pathology, Radboud University Nijmegen Medical Centre 3 Department of Paediatric Nephrology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, The Netherlands
Lambert P. van den Heuvel, Department of Paediatric Nephrology, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Tel: +31-24-3617983; Fax: +31-24-3618900; E-mail: B.vandenheuvel{at}cukz.umcn.nl
 |
Abstract |
|---|
Background. Focal segmental glomerulosclerosis (FSGS) is a major cause of steroid-resistant nephrotic syndrome in childhood with a central role for the podocytes in the pathogenesis. Mutated proteins expressed in podocytes cause proteinuria. The role of combined gene defects in the development of FSGS is less clear.
Methods. We analysed seven podocyte genes known to cause proteinuria and FSGS in a group of 19 non-familial childhood-onset steroid-resistant FSGS patients. These genes include NPHS1, NPHS2, ACTN4, CD2AP, WT-1, TRPC6 and PLCE1. We also screened for the mitochondrial A3243G DNA transition associated with the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), and occasionally FSGS.
Results. No mutations were found in the ACTN4 and TRPC6 genes, and no mitochondrial A3243G DNA transition was found in our group of patients. Two patients showed mutations in the CD2AP gene, one combined with an NPHS2 mutation. A tri-allelic hit was found in a patient carrying compound heterozygous NPHS2 mutations and a heterozygous NPHS1 mutation. In another patient a de novo WT-1 mutation was found combined with a heterozygous NPHS1 mutation, and finally two patients showed three heterozygous PLCE1 mutations.
Conclusions. In our rather small group of 19 steroid-resistant FSGS patients, we found 11 mutations in podocyte genes in 6 patients. In four of them the found mutations could explain the pathology. Our data suggest that combined gene defects in podocyte genes may play a role in the development of FSGS.
Keywords: bigenic; CD2AP; focal segmental glomerulosclerosis en podocin
Received for publication: 15. 5.07
Accepted in revised form: 20. 3.08
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. A.C. Kyrieleis, M. M. Lowik, I. Pronk, H. R.M. Cruysberg, J. A.M. Kremer, W. J.G. Oyen, B. L.P. van den Heuvel, J. F.M. Wetzels, and E. N. Levtchenko Long-Term Outcome of Biopsy-Proven, Frequently Relapsing Minimal-Change Nephrotic Syndrome in Children Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pierides, K. Voskarides, Y. Athanasiou, K. Ioannou, L. Damianou, M. Arsali, M. Zavros, M. Pierides, V. Vargemezis, C. Patsias, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2721 - 2729. [Abstract] [Full Text] [PDF]
|
|